We are committed to the professional and patient communities we serve. In the spirit of this commitment, we invite ongoing feedback
331 Treble Cove Rd.
N. Billerica, MA 01862
US Customer Service/Order PYLARIFY®
Hours: 8:30 am to 8:00 pm ET, Monday to Friday
PYLARIFY® REIMBURSEMENT RESOURCES
Call Toll Free: 844-339-8514
Lantheus cannot guarantee coverage or payment for products or procedures. Payer policies can vary widely and third party payment for medical products and services is affected by numerous factors. It is always the provider’s responsibility to determine and submit appropriate codes, charges, and modifiers for services rendered. For more specific information, contact your third-party payer directly in order to obtain up-to-date coverage, coding, and payment information.
ADVERSE EVENT AND PRODUCT QUALITY COMPLAINT REPORTS
Adverse Events and Product Quality Complaint Reports must be reported through the following channels:
Press Option 2 for Adverse Events
Press Option 2 for Product Quality Complaints
If you would like a sales representative to contact you, please complete the form below.
*Please complete the required fields below.
INDICATION & IMPORTANT
PYLARIFY® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer:
- with suspected metastasis who are candidates for initial definitive therapy.
- with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level.
- FDA clearance letter for aPROMISE X. Food and Drug Administration. April 29, 2022.